EX-FILING FEES

Exhibit 107.1

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Aerie Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type

Security

Class Title

Fee
Calculation
Rule⁽³⁾

Amount
Registered⁽¹⁾

Proposed
Maximum
Offering Price Per
Unit

Maximum Aggregate
Offering Price

Fee Rate

Amount of
Registration Fee

Equity

Common Stock, $0.001 par value per share

Other

2,700,000⁽²⁾

$7.95⁽³⁾

$21,465,000.00

$0.0000927

$1,989.81

Total Offering Amounts

$21,465,000.00

$1,989.81

Total Fee Offsets

Net Fee Due

$1,989.81

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the registration statement on Form S-8 (the “Registration Statement”) shall also cover any additional shares of common stock, par value $0.001 per share (“Common Stock”), of Aerie Pharmaceuticals, Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, reclassification, recapitalization, spin-off or any other similar transaction that results in an increase in the number of the outstanding shares of the Registrant’s Common Stock.

(2)	Represents 2,700,000 shares of the Registrant’s Common Stock authorized for issuance under the Aerie Pharmaceuticals, Inc. Second Amended and Restated Inducement Award Plan.

(3)

Estimated in accordance with Rules 457(c) and (h) of the Securities Act, solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $7.95 was computed by averaging the high and low prices of a share of the Registrant’s Common Stock as reported on The Nasdaq Global Market on March 8, 2022.